Abstract
Objective
The objective of this study was to develop a combined model based on radiomics features of Sonazoid contrast-enhanced ultrasound (CEUS) during the Kupffer phase and to evaluate its value in differentiating well-differentiated hepatocellular carcinoma (w-HCC) from atypical benign focal liver lesions (FLLs).
Methods
A total of 116 patients with preoperatively Sonazoid-CEUS confirmed w-HCC or benign FLL were selected from a prospective multiple study on the clinical application of Sonazoid in FLLs conducted from August 2020 to March 2021. According to the randomization principle, the patients were divided into a training cohort and a test cohort in a 7:3 ratio. Seventy-nine patients were used for establishing and training the radiomics model and combined model. In comparison, 37 patients were used for validating and comparing the performance of the models. The diagnostic efficacy of the models for w-HCC and atypical benign FLLs was evaluated using ROCs curves and decision curves. A combined model nomogram was created to assess its value in reducing unnecessary biopsies.
Results
Among the patients, there were 55 cases of w-HCC and 61 cases of atypical benign FLLs, including 28 cases of early liver abscess, 16 cases of atypical hepatic hemangioma, 8 cases of hepatocellular dysplastic nodules (DN), and 9 cases of focal nodular hyperplasia (FNH). The radiomics model and combined model we established had AUCs of 0.905 and 0.951, respectively, in the training cohort, and the AUCs of the two models in the test cohort were 0.826 and 0.912, respectively. The combined model outperformed the radiomics feature model significantly. Decision curve analysis demonstrated that the combined model achieved a higher net benefit within a specific threshold probability range (0.25 to 1.00). A nomogram of the combined model was developed.
Conclusion
The combined model based on the radiomics features of Sonazoid-CEUS in the Kupffer phase showed satisfactory performance in diagnosing w-HCC and atypical benign FLLs. It can assist clinicians in timely detecting malignant FLLs and reducing unnecessary biopsies for benign diseases.
Similar content being viewed by others
Abbreviations
- FLLs:
-
Focal liver lesions
- CECT:
-
Contrast-enhanced computed tomography
- US:
-
Ultrasound
- CT:
-
Contrast-enhanced computed tomography
- MRI:
-
Magnetic resonance imaging
- HCC:
-
Hepatocellular carcinoma
- HBV:
-
Hepatitis B virus
- HCV:
-
Hepatitis C virus
- FNH:
-
Focal nodular hyperplasia
- DN:
-
Dysplastic nodule
- DCA:
-
Decision curve analysis
- AUC:
-
Area under the curve
- MLP:
-
Multilayer perceptron
- ROC:
-
Receiver operating characteristic
- ROIs:
-
Region of interests
- CV:
-
Cross-validation
- MSE:
-
Mean square error
- AFP:
-
Alpha fetoprotein
- BMI:
-
Body mass index
- APHE:
-
Arterial phase high enhanced
- w-HCC:
-
Well-differentiated hepatocellular carcinoma
- BMUS:
-
B-mode ultrasound
- SWE:
-
Shear wave elastography
- SWV:
-
Shear wave viscosity
References
Sung H, Ferlay J, Siegel RL, et al. "Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries" in CA: A Cancer Journal for Clinicians, 2021, 71(3): 209-249.
"Guidelines for the Diagnosis and Treatment of Primary Liver Cancer" in Chinese Journal of Practical Surgery, 2022, 42(03):241-273.
Guo HB, Wang JH. "Impact of Contrast Ultrasound Diagnosis for Patients with Liver Cancer" in Medicine (Baltimore), 2019 May;98(19):e15445.
Dietrich CF, Nolsøe CP, Barr RG, et al. "Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) in the Liver - Update 2020 - WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS" in Ultraschall Med, 2020 Oct;41(5):562-585.
Kono Y, Lyshchik A, Cosgrove D, et al. "Contrast Enhanced Ultrasound (CEUS) Liver Imaging Reporting and Data System (LI-RADS(R)): The Official Version by the American College of Radiology (ACR)" in Ultraschall Med, 2017, 38(1): 85-86.
Lin M, Lu DS, Duan Y, et al. "Cirrhotic Nodule Transformation to Hepatocellular Carcinoma: Natural History and Predictive Biomarkers on Contrast-Enhanced Ultrasound" in AJR Am J Roentgenol, 2020 Jan; 214(1):96-104.
Okuno M, Newhook TE, Joechle K, et al. "Characteristics of Atypical Large Well-Differentiated Hepatocellular Carcinoma: A Specific Subtype of Hepatocellular Carcinoma?" in HPB (Oxford), 2020 Apr;22(4):545-552.
Lee JY, Minami Y, Choi BI, et al. "The AFSUMB Consensus Statements and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound using Sonazoid" in Ultrasonography, 2020 Jul;39(3):191-220.
Omata M, Cheng AL, Kokudo N, et al. "Asia-Pacific Clinical Practice Guidelines on the Management of Hepatocellular Carcinoma: A 2017 Update" in Hepatology International, 2017 Jul;11(4):317-370.
Lambin P, Rios-Velazquez E, Leijenaar R, et al. "Radiomics: Extracting More Information from Medical Images Using Advanced Feature Analysis" in European Journal of Cancer, 2012 Mar;48(4):441-6.
Zhang Q, Xiao Y, Suo J, et al. Sonoelastomics for Breast Tumor Classification: A Radiomics Approach with Clustering-Based Feature Selection on Sonoelastography. Ultrasound Med Biol. 2017 May;43(5):1058-1069.
Yao Z, Dong Y, Wu G, et al. Preoperative diagnosis and prediction of hepatocellular carcinoma: Radiomics analysis based on multi-modal ultrasound images. BMC Cancer. 2018 Nov 12;18(1):1089
Liu F, Liu D, Wang K, et al. Deep Learning Radiomics Based on Contrast-Enhanced Ultrasound Might Optimize Curative Treatments for Very-Early or Early-Stage Hepatocellular Carcinoma Patients. Liver Cancer. 2020 Aug;9(4):397-413.
Chuanji Z, Zheng W, Shaolv L, et al. Comparative study of radiomics, tumor morphology, and clinicopathological factors in predicting overall survival of patients with rectal cancer before surgery. Transl Oncol. 2022 Apr;18:101352
Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ. 2015 Jan 7;350:g7594
Mokrane FZ, Lu L, Vavasseur A, et al. Radiomics machine learning signature for diagnosis of hepatocellular carcinoma in cirrhotic patients with indeterminate liver nodules[J]. Eur Radiol, 2020, 30(1): 558-70.
Stollmayer R, Budai BK, Tóth A, et al. Diagnosis of focal liver lesions with deep learning-based multi-channel analysis of hepatocyte-specific contrast-enhanced magnetic resonance imaging[J]. World J Gastroenterol, 2021, 27(35): 5978-88.
Wu M, Li L, Wang J, et al. Contrast-enhanced US for characterization of focal liver lesions: a comprehensive meta-analysis. Eur Radiol. 2018 May;28(5):2077-2088.
Yang WY, Park HS, Kim YJ, et al. Visibility of focal liver lesions: Comparison between Kupffer phase of CEUS with Sonazoid and hepatobiliary phase of gadoxetic acid-enhanced MRI. J Clin Ultrasound. 2017 Nov 12;45(9):542-550.
Park HS, Kim YJ, Yu MH, et al. Real-time contrast-enhanced sonographically guided biopsy or radiofrequency ablation of focal liver lesions using perflurobutane microbubbles (Sonazoid): value of Kupffer-phase imaging. J Ultrasound Med. 2015 Mar;34(3):411-21.
Kondo T, Maruyama H, Kiyono S, et al. Intensity-Based Assessment of Microbubble-Enhanced Ultrasonography: Phase-Related Diagnostic Ability for Cellular Differentiation of Hepatocellular Carcinoma. Ultrasound Med Biol. 2015 Dec;41(12):3079-87.
Takahashi M, Maruyama H, Ishibashi H, et al. Contrast-enhanced ultrasound with perflubutane microbubble agent: evaluation of differentiation of hepatocellular carcinoma. AJR Am J Roentgenol. 2011 Feb;196(2):W123-31.
Sugimoto K, Shiraishi J, Tanaka H, et al. Computer-aided diagnosis for estimating the malignancy grade of hepatocellular carcinoma using contrast-enhanced ultrasound: an ROC observer study. Liver Int. 2016 Jul;36(7):1026-32.
Maruyama H, Takahashi M, Sekimoto T, Kamesaki H, Shimada T, Kanai F, Yokosuka O. Heterogeneity of microbubble accumulation: a novel approach to discriminate between well-differentiated hepatocellular carcinomas and regenerative nodules. Ultrasound Med Biol. 2012 Mar;38(3):383-8.
Sugimoto K, Moriyasu F, Saito K, Yoshiara H, Imai Y. Kupffer-phase findings of hepatic hemangiomas in contrast-enhanced ultrasound with sonazoid. Ultrasound Med Biol. 2014 Jun;40(6):1089-95.
Lee J, Jeong WK, Lim HK, Kim AY. Focal Nodular Hyperplasia of the Liver: Contrast-Enhanced Ultrasonographic Features With Sonazoid. J Ultrasound Med. 2018 Jun;37(6):1473-1480.
Kudo M, Hatanaka K, Inoue T, Maekawa K. Depiction of portal supply in early hepatocellular carcinoma and dysplastic nodule: value of pure arterial ultrasound imaging in hepatocellular carcinoma. Oncology. 2010 Jul;78 Suppl 1:60-7.
Claudon M, Dietrich CF, Choi BI, et al. Guidelines and good clinical practice recommendations for contrast-enhanced ultrasound (CEUS) in the liver--update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultraschall Med. 2013 Feb;34(1):11-29.
Suzuki K, Okuda Y, Ota M, et al. Diagnosis of hepatocellular carcinoma nodules in patients with chronic liver disease using contrast-enhanced sonography: usefulness of the combination of arterial- and Kupffer-phase enhancement patterns. J Ultrasound Med. 2015 Mar;34(3):423-33.
Ta CN, Kono Y, Eghtedari M, et al. Focal Liver Lesions: Computer-aided Diagnosis by Using Contrast-enhanced US Cine Recordings. Radiology. 2018 Mar;286(3):1062-1071.
Funding
This work was supported by Grants 82172027 from the National Scientific Foundation Committee of China.
Author information
Authors and Affiliations
Contributions
Ping Liang, Xiaoling Yu, Zhen Wang, and Jundong Yao contributed to concept and design. All authors contributed to experiments and procedures. Zhen Wang and Jundong Yao contributed to writing of article. Zhen Wang and Shuo Wang contributed to statistical analysis. Xiaoling Yu contributed to supervision and is the graduate mentor.
Corresponding authors
Ethics declarations
Conflict of interest
All authors disclosed no relevant relationships.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Wang, Z., Yao, J., Jing, X. et al. A combined model based on radiomics features of Sonazoid contrast-enhanced ultrasound in the Kupffer phase for the diagnosis of well-differentiated hepatocellular carcinoma and atypical focal liver lesions: a prospective, multicenter study. Abdom Radiol (2024). https://doi.org/10.1007/s00261-024-04253-4
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00261-024-04253-4